Education
About Us
Working with TipRanks
Follow Us
Amgen (AMGN)
NASDAQ:AMGN
Total Valuation
Amgen has a market cap or net worth of $159.61B. The enterprise value is $199.23B.
Market Cap$159.61B
Enterprise Value$199.23B
Share Statistics
Amgen has 538,361,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding538,361,900
Owned by Insiders0.19%
Owned by Institutions22.22%
Financial Efficiency
Amgen’s return on equity (ROE) is 0.70 and return on invested capital (ROIC) is 8.91%.
Return on Equity (ROE)0.70
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)8.91%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee1.19M
Profits Per Employee146.07K
Employee Count28,000
Asset Turnover0.36
Inventory Turnover1.84
Valuation Ratios
The current PE Ratio of Amgen is 24.3. Amgen’s PEG ratio is ―.
PE Ratio24.3
PS Ratio―
PB Ratio―
Price to Fair Value23.99
Price to FCF―
Price to Operating Cash Flow12.96
PEG Ratio―
Income Statement
In the last 12 months, Amgen had revenue of 33.42B and earned 4.09B in profits. Earnings per share was 7.56.
Revenue33.42B
Gross Profit20.57B
Operating Income7.26B
Pretax Income4.61B
Net Income4.09B
EBITDA13.36B
Earnings Per Share (EPS)7.56
Cash Flow
In the last 12 months, operating cash flow was 12.01B and capital expenditures -1.41B, giving a free cash flow of 10.61B billion.
Operating Cash Flow12.01B
Free Cash Flow10.61B
Free Cash Flow per Share19.70
Dividends & Yields
Amgen pays an annual dividend of $2.38, resulting in a dividend yield of 3.16%
Dividend Per Share$2.38
Dividend Yield3.16%
Payout Ratio65.75%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.37
52-Week Price Change-8.70%
50-Day Moving Average293.20
200-Day Moving Average287.00
Relative Strength Index (RSI)49.21
Average Volume (3m)2.02M
Important Dates
Amgen upcoming earnings date is Oct 29, 2025, After Close (Confirmed).
Last Earnings DateAug 5, 2025
Next Earnings DateOct 29, 2025
Ex-Dividend DateAug 22, 2025
Financial Position
Amgen as a current ratio of 1.26, with Debt / Equity ratio of 756.65%
Current Ratio1.26
Quick Ratio0.95
Debt to Market Cap0.43
Net Debt to EBITDA3.60
Interest Coverage Ratio2.30
Taxes
In the past 12 months, Amgen has paid 519.00M in taxes.
Income Tax519.00M
Effective Tax Rate0.11
Enterprise Valuation
Amgen EV to EBITDA ratio is 14.16, with an EV/FCF ratio of 18.20.
EV to Sales5.66
EV to EBITDA14.16
EV to Free Cash Flow18.20
EV to Operating Cash Flow16.46
Balance Sheet
Amgen has $8.03B in cash and marketable securities with $56.20B in debt, giving a net cash position of $48.18B billion.
Cash & Marketable Securities$8.03B
Total Debt$56.20B
Net Cash$48.18B
Net Cash Per Share$89.49
Tangible Book Value Per Share-$74.79
Margins
Gross margin is 64.47%, with operating margin of 21.71%, and net profit margin of 12.24%.
Gross Margin64.47%
Operating Margin21.71%
Pretax Margin13.79%
Net Profit Margin12.24%
EBITDA Margin39.96%
EBIT Margin23.23%
Analyst Forecast
The average price target for Amgen is $325.25, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$325.25
Price Target Upside11.15% Upside
Analyst ConsensusModerate Buy
Analyst Count21
Revenue Growth Forecast13.10%
EPS Growth Forecast110.67%